Seattle Treatment Education Project

Treatment Alert

October 15, 2002

Erratum: In the STEP Perspective (Volume 02, Number 2, Fall 2002), in an article titled "Viread-Videx EC Drug Interactions: What's a Person to Do?" it was incorrectly stated that the 250 mg dose of Videx (ddI) is not available in the enteric coated preparation. The 250 mg dose of Videx is available as Videx EC. What is not available is the pharmacokinetic (pK) data when this dose is administered with tenofovir to determine if it is the correct dose of Videx EC that should be used with tenofovir.

Back to the STEP Ezine Volume 1, Issue 42 contents page.

This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine.

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Back From the Brink: A Blog Entry by Thomas DeLorenzo

World AIDS Day 2009: Home

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.